Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer
Frontiers in Bioscience-Landmark · 2026
DOI: 10.31083/fbl46641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2026. Verfasst von Cinzia Garofalo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catan…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Ovarian Neoplasms, Ferroptosis, Carbolines. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High-grade ovarian cancer (HGOC) is a heterogeneous and aggressive malignancy with a tumor microenvironment (TME) that suppresses immune responses, limiting immunotherapy efficacy. Ferroptosis, an iron-dependent form of regulated cell death, has emerged as a potential therapeutic target.
Methods
We investigated the immunomodulatory effects of the ferroptosis inducer RAS-Selective Lethal 3 (RSL3) in four HGOC cell lines (ES-2, OVCAR-5, HEY, PEO-1) using flow cytometry and lactate dehydrogenase (LDH) release assays.
Results
RSL3 modulated Natural Killer (NK) ligand expression in a cell line-dependent manner, resulting in differential susceptibility to NK cell-mediated cytotoxicity. OVCAR-5 cells became more susceptible to NK cell killing after treatment, whereas HEY cells showed reduced susceptibility, and ES-2 and PEO-1 cells exhibited minimal changes.
Conclusions
Ferroptosis induction alone does not consistently enhance NK cell-mediated cytotoxicity in HGOC cells. These findings underscore the heterogeneity of tumor responses and highlight the need for further studies, particularly in in vivo models, to elucidate mechanisms linking ferroptosis to immune recognition and thereby inform therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.
- SOC di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliero Universitaria "Renato Dulbecco", 88100 Catanzaro, Italy.
- Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Campus "S. Venuta", 88100 Catanzaro, Italy.
Zitieren
APA
Garofalo, C., Scicchitano, S., Vecchio, E., Nisticò, A., Quaresima, B., Stella, B., De Marco, C., Biamonte, F., & Faniello, M. C. (2026). Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46641
Vancouver
Garofalo C, Scicchitano S, Vecchio E, Nisticò A, Quaresima B, Stella B, et al. Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer. Frontiers in Bioscience-Landmark. 2026. doi:10.31083/fbl46641
BibTeX
@article{Garofalo2026,
author = {Garofalo, Cinzia and Scicchitano, Stefania and Vecchio, Eleonora and Nisticò, Antonia and Quaresima, Barbara and Stella, Beatrice and De Marco, Carmela and Biamonte, Flavia and Faniello, Maria Concetta},
title = {Ferroptosis Induction is Insufficient to Ensure NK Cell Activation in High-Grade Ovarian Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
doi = {10.31083/fbl46641}
}
EUVIMED